The firm's Q3 2024 revenues rose 33 percent year over year as both its genomics and data and services revenues increased in the double-digit percent range.
NEW YORK — UK-based iFast Diagnostics said on Tuesday that it has raised $6.5 million in seed funding. The financing round was led by KHP Ventures and included EInk, Raw Ventures, and OKG Capital, as ...
NEW YORK – Digital pathology company OptraScan announced on Tuesday that it has closed a $30 million Series B financing round. The round was led by molecular diagnostics firm Molbio Diagnostics. The ...
Fadel Alshalabi, owner and CEO of Crestar Labs, and Samuel Harris, owner of Flojo Recruiting conspired to bill Medicare and Medicaid for millions of dollars in genetic test orders.
The firm reported a 13 percent jump in its non-COVID molecular diagnostics revenues year over year while its breast health and GYN Surgical business revenues rose 6 percent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback